The Boston-based fund company has added more than $50 billion this year, mostly from inflows.
Earnings, economic growth, Fed policy, trade policy and corporate credit are all in the mix as investors try to figure out which way stocks are heading.
Regulator highlights reps engaging in unsuitable product sales and firms not conducting appropriate due diligence.
Long out of favor, liquid alt funds shine as noncorrelated portfolio ballast.
Taking a deduction for out-of-pocket medical expenses will face a higher bar in 2019.
Funds are built for professional investors sick of waiting for SEC to approve a bitcoin ETF.
Diversification is making it harder than usual to keep up with the S&P 500.
The rout had no shortage of explanations among Wall Street traders.
IUL's market share is two-and-a-half-times larger than it was at the beginning of the decade.
Investors had started warming up to developing-nation funds well before last week's optimism about U.S.-China trade tensions and the outlook for Fed policy.
Investors worry rising rates might slow lending and raise the amount the banks have to pay customers in interest.
Assets under management with environmental, social and governance strategies have grown 44% over two years in the U.S.
Wall Street is split on whether good news on the Fed and easing of trade tensions were enough to overcome weakening economic fundamentals.
Survey highlights the level of misunderstanding, which could lead to disappointed plan participants and suboptimal behavior.
Latest rally leaves traders little room to ratchet down expectations for Fed rate hikes next year.
Columnist is one of the owners of a VA contract that insurer is cutting fees on.
As investors steer clear of risk, ETFs holding utilities, consumer staples and health care companies benefit.
Last year's tax overhaul made state and local government debt less attractive to financial institutions.
Medicare doesn't cover medical costs outside the U.S.
Firm is raising millions without state or federal filings.
